Education
B.A., Boston College, Political Science and English
J.D., Brooklyn Law School
Bar Admissions
California State Bar
New Jersey State Bar
New York State Bar
United States District Courts for the Southern and Eastern Districts of New York
United States District Court for the District of New Jersey
Ms. Millioen is a senior associate at DOCB. At DOCB, she represents insurers in litigation involving life, health, and disability insurance, including matters involving allegations of ERISA, bad faith, rescission, and agent liability. Ms. Millioen has extensive experience litigating Interpleader matters in state and federal courts across the country. Additionally, Ms. Millioen defends clients in commercial litigation matters involving allegations of breach of contract, fraud, misrepresentation and breach of fiduciary duty.
Prior to joining the firm, Ms. Millioen worked as general counsel to clients in the hospitality industry, where she focused on labor and employment matters. Ms. Millioen also worked at Paul, Weiss, Rifkind, Wharton & Garrison LLP, for ten years where she represented clients in complex commercial litigation, regulatory investigations, and securities litigation.
Speeches and Publications
UPDATES ON BUSINESS INTERRUPTION COVERAGE DISPUTES RELATING TO COVID-19
By James M. Lenaghan and Tiffany C. Millioen
To date, hundreds of businesses have filed lawsuits against insurers arising out of denials for COVID-19 business interruption losses. Most of this litigation is in its early stages and is being closely watched by insurers and policyholders. In addition to litigation, regulators are issuing guidance and legislators are proposing bills that would affect coverage for the losses. This article provides a snapshot of the situation at this time.
On April 7, 2020, Tiffany Millioen participated in a panel discussion webinar sponsored by the National Association of Minority and Women Owned Law Firms (NAMWOLF) entitled “Insurance in the Time of Pandemic.” The panelists analyzed the insurability of business losses caused by the COVID-19 pandemic, including insurer defenses to coverage litigation.